LUNA Luna Innovations Incorporated

Luna Innovations Incorporated (NASDAQ: LUNA), a company focusing on sensing, instrumentation and nanotechnology, today announced its financial results for the first quarter ended March 31, 2010.

As compared to the same quarter last year, product and license revenue increased by 29%, from $1.6 million in the first quarter of 2009 to $2.1 million in the first quarter of 2010, while total revenue decreased by 7%, from $8.5 million in the first quarter of 2009 to $7.9 million in the first quarter of 2010. The decrease in total revenue was largely the result of lower pass-through costs for subcontracts and materials under a research contract in the company’s technology development business segment. Gross profit increased from $2.7 million for the first quarter of 2009 to $2.8 million for the first quarter of 2010. The company reported a net loss attributable to common shareholders of $1.3 million, or $0.10 per common share, for the first quarter of 2010, as compared to a net loss of $40.9 million, or $3.66 per common share for the first quarter of 2009. The net loss for the first quarter of 2009 included one-time charges of $36.3 million for a litigation reserve and $1.3 million for the impairment of intangible assets, and a $0.6 million charge related to the valuation allowance provided against the company’s deferred tax asset. Adjusted EBITDA, which is earnings before interest, taxes, depreciation and amortization, excluding non-cash stock-based compensation expense, non-cash charges for impairment of intangible assets and charges related to the company’s litigation with Hansen Medical, Inc. and its Chapter 11 reorganization, improved to positive $0.5 million for the first quarter of 2010, as compared to negative $0.3 million for the first quarter of 2009. The company consummated a settlement of its litigation with Hansen and emerged from Chapter 11 reorganization in January 2010.

Kent Murphy, Chief Executive Officer, provided this overview of Luna’s results: “I am very pleased with our results since emerging from Chapter 11 reorganization in January. Recovery in demand for our fiber optic equipment during the quarter, along with our continued focus on operating expenses, has resulted in significant improvement in our core operating results that we believe represent progress toward profitability.”

First Quarter Financial Highlights

-- Total revenues decreased by 7%, from $8.5 million for the first quarter of 2009 to $7.9 million for the first quarter of 2010.

-- Product and license revenues increased by 29% to approximately $2.1 million for the first quarter of 2010 from $1.6 million for the first quarter of 2009. Technology development revenues decreased by 16% to $5.8 million for the first quarter of 2010 from $6.9 million for the first quarter of 2009, primarily due to lower pass-through costs included in 2010 revenues.

-- Gross profit for the first quarter of 2010 increased to $2.8 million, or 36% of total revenues, from $2.7 million, or 32% of total revenues, for the corresponding period of 2009.

-- Selling, general and administrative expenses decreased by 19% to $3.4 million, or 43% of total revenues for the first quarter of 2010, from $4.2 million, or 50% of total revenues, for the first quarter of 2009.

-- Total operating expenses, excluding litigation and reorganization costs, decreased to $3.5 million, or 45% of total revenues for the first quarter of 2010, from $4.4 million, or 52% of total revenues, for the first quarter of 2009.

-- Adjusted EBITDA excluding litigation and bankruptcy related items increased to $0.5 million in the first quarter of 2010 from negative $0.3 million in the first quarter of 2009.

-- Net loss improved to $1.3 million for the first quarter of 2010, compared to a net loss of $40.9 million for the first quarter of 2009, primarily driven by reductions in amounts accrued with respect to the Hansen litigation in 2009 as well as expenses recognized with respect to impairment of intangible assets and the valuation of deferred tax assets as of March 2009.

-- Cash and cash equivalents totaled $6.5 million at March 31, 2010, as compared to $13.2 million at March 31, 2009. The company executed a revolving line of credit providing up to $5 million in borrowing capacity. At March 31, 2010, $2.5 million was outstanding under the line of credit.

First Quarter Business Highlights

-- The company emerged from Chapter 11 reorganization on January 12, 2010 with a court approved reorganization plan that provided for payment of 100% of valid claims and allowed stockholders to retain their equity shares.

-- The first Optical Vector Analyzer™ (OVA) 5000 products were shipped to customers. The OVA 5000 is a device for single-measurement, all-parameter analysis of fiber optic components and assemblies.

-- Luna began work under the development and supply agreement with Hansen Medical, entered into as part of the litigation settlement, pursuant to which Luna is integrating its fiber optic shape sensing technology into Hansen’s medical robotic instruments.

-- Luna’s technology development division was awarded 12 contracts in the first quarter, including eight Phase Is, two Phase 2s, one option to continue a contract and one subcontract on a Phase I.

Outlook 2010

Based on information as of May 11, 2010, the company continues to expect total revenue for 2010 to be in the range of $35.5 million to $38.0 million, consisting of product and license revenue of $9.5 million to $11.0 million and technology development revenue of $26.0 million to $27.0 million. Also for 2010, the company anticipates a GAAP net loss in the range of $2.8 million to $3.5 million, with positive adjusted EBITDA of $2.4 million to $3.9 million. For the second quarter of 2010, the company expects revenue of approximately $8.5 million to $9.5 million and a net loss of approximately $0.5 million to $1.0 million.

Non-GAAP Measures

In evaluating the operating performance of its business, Luna’s management excludes certain charges and credits that are required by generally accepted accounting principles (“GAAP”). These non-GAAP results provide useful information to both management and investors by excluding items that the company believes may not be indicative of its operating performance, because either they are unusual and the company does not expect them to recur in the ordinary course of its business or they are unrelated to the ongoing operation of the business in the ordinary course. These non-GAAP measures should be considered in addition to results and guidance prepared in accordance with GAAP, but should not be considered a substitute for, or superior to, GAAP results. The non-GAAP measures included in this press release have been reconciled to the nearest GAAP measure in the table following the financial statements attached to this press release.

Conference Call Information

As previously announced, Luna Innovations will conduct an investor conference call at 5:00 p.m. (ET) today to discuss its financial results and business developments for the first quarter of 2010. The call can be accessed by dialing 866.383.8003 domestically or 617.597.5330 internationally prior to the start of the call. The access code is 33764338. Investors are advised to dial in at least five minutes prior to the call to register. The conference call will also be webcast live over the Internet. The webcast can be accessed by logging on to the “Investor Relations” section of the Luna Innovations website, http://www.lunainnovations.com, prior to the event. The webcast will be archived under the “Webcasts and Presentations” section of the Luna Innovations website for at least 30 days following the conference call.

About Luna Innovations:

Luna Innovations Incorporated (www.lunainnovations.com) is focused on sensing and instrumentation, and pharmaceutical nanomedicines. Luna develops and manufactures new-generation products for the healthcare, telecommunications, energy and defense markets. The company’s products are used to measure, monitor, protect and improve critical processes in the markets we serve. Through its disciplined commercialization business model, Luna has become a recognized leader in transitioning science to solutions. Luna is headquartered in Roanoke, Virginia.

Forward Looking Statements:

The statements in this release that are not historical facts constitute “forward-looking statements” made pursuant to the safe harbor provision of the Private Securities Litigation Reform Act of 1995 that involve risks and uncertainties. These statements include our expectations regarding financial results for the second quarter and full year 2010 and the Company’s future profitability. Management cautions the reader that these forward-looking statements are only predictions and are subject to a number of both known and unknown risks and uncertainties, and actual results, performance, and/or achievements of the Company may differ materially from the future results, performance, and/or achievements expressed or implied by these forward-looking statements as a result of a number of factors. These factors include, without limitation the fact that the outlook for the second quarter of and full year 2010 could change, and also include, without limitations, those risks and uncertainties set forth in the Company’s periodic reports and other filings with the Securities and Exchange Commission. Such filings are available at the SEC’s website at http://www.sec.gov, and at the company’s website at http://www.lunainnovations.com. The statements made in this release are based on information available to the company as of the date of this release and Luna Innovations undertakes no obligation to update any of the forward-looking statements after the date of this release.

 

Luna Innovations Incorporated Consolidated Statements of Operations

  Three months ended, March 31,   2010       2009   (unaudited) Revenues: Technology development $ 5,811,094 $ 6,882,372 Product and license   2,074,697     1,611,184   Total revenues   7,885,791     8,493,556     Cost of revenues Technology development 3,832,342 4,897,756 Product and license   1,219,241     878,601   Total cost of revenues   5,051,583     5,776,357     Gross profit   2,834,208     2,717,199     Operating expenses: Selling, general and administrative 3,421,262 4,235,588 Research, development and engineering 509,899 995,643 Litigation reserve - 36,303,643 Impairment of intangible assets   -     1,310,598   Total operating expense 3,931,161 42,845,472   Operating loss   (1,096,953 )   (40,128,273 )   Other expense Interest expense 84,014 158,988 Other   14,877     923   Total other expense   98,891     159,911     Loss before income taxes (1,195,844 ) (40,288,184 )   Income tax expense   -     600,000     Net loss (1,195,844 ) (40,888,184 )   Dividends declared on preferred stock 81,633 -     Net loss attributable to common shareholders $ (1,277,477 ) $ (40,888,184 )   Net loss per share of common stock $ (0.10 ) $ (3.66 )    

Luna Innovations Incorporated Consolidated Balance Sheets

  March 31, December 31,   2010     2009   (unaudited) Assets Current assets: Cash and cash equivalents $ 6,467,080 $ 5,228,802 Accounts receivable, net 7,754,801 7,203,203 Inventory 2,822,059 2,890,364 Prepaid expenses 672,685 560,964 Other current assets   46,916     729,532   Total current assets 17,763,541 16,612,865   Property and equipment, net 3,855,226 4,129,015 Intangible assets, net 553,794 580,785 Other assets 359,585 435,259     Total assets $ 22,532,146   $ 21,757,924     Liabilities and stockholders' equity (deficit)

Current liabilities not subject to compromise:

Line of credit $ 2,500,000 $ - Current portion of long term debt 1,096,981 - Accounts payable 1,881,731 1,142,267 Accrued liabilities 3,978,413 3,379,339 Deferred credits   1,355,541     1,034,526     Total current liabilities 10,812,666 5,556,132   Long term debt 3,903,019 - Liabilities subject to compromise   -     19,062,000    

Total liabilities

  14,715,685     24,618,132     Stockholders' equity (deficit) Preferred stock 1,322 - Common stock 12,786 11,352 Stock dividend not yet issued 81,633 - Additional paid-in capital 53,098,455 41,228,698 Accumulated deficit   (45,377,735 )   (44,100,258 )   Total stockholders' equity (deficit) 7,816,461 (2,860,208 )    

Total liabilities and stockholders' equity (deficit)

  22,532,146     21,757,924    

Luna Innovations Incorporated Consolidated Statements of Cash Flows

    Three months ended March 31,   2010       2009   (unaudited) Cash flows used in operating activities: Net loss $ (1,195,844 ) $ (40,888,184 )

Adjustments to reconcile not loss to cash used in operating activities:

Depreciation and amortization 328,959 619,788 Impairment of intangible assets - 1,310,598 Share-based compensation 887,340 789,511 Warrant expense 46,997 - Deferred tax expense - 600,000 Changes in asset and liabilities: Accounts receivable (551,599 ) (589,248 ) Inventory 80,168 (21,336 ) Other current assets 570,896 (5,317 ) Other assets 33,446 17,728 Accounts payable and accrued expenses (1,970,872 ) (263,459 ) Litigation reserve - 36,303,643 Deferred credits   328,525     200,260   Net cash used in operating activities   (1,441,984 )   (1,926,016 )   Cash flows used in investing activities Acquisition of property and equipment (11,010 ) (34,037 ) Capitalized intellectual property costs   (34,362 )   (30,749 ) Net cash used in investing activities   (45,372 )   (64,786 )   Cash flows provided by (used in) financing activities Payments on capital lease obligation (1,367 ) (2,799 ) Payments on debt obligation - (357,143 ) Borrowings under line of credit 2,500,000 - Proceeds from exercise of options   227,001     10,824  

Net cash provided by (used in) financing activities

  2,725,634     (349,118 )   Net change in cash 1,238,278 (2,339,920 )   Cash at beginning of period   5,228,802     15,518,960   Cash at end of period $ 6,467,080   $ 13,179,040      

Luna Innovations Incorporated Reconciliation of EBITDA and Adjusted EBITDA to Net Income/ (Loss)

    Three Months Ended March 31,   2010       2009   (unaudited) Reconciliation of net loss to adjusted EBITDA less litigation   Net loss $ (1,195,844 ) $ (40,888,184 )   Interest 84,014 158,988 Taxes - 600,000 Depreciation and amortization 328,959 619,788 Impairment of intangible assets   -     1,310,598   EBITDA (782,871 ) (38,198,810 )   Share based compensation   934,337     789,511   Adjusted EBITDA 151,466 (37,409,299 )   Litigation reserve - 36,303,643

Fees associated with litigation and reorganization

  382,887     790,381   Adjusted EBITDA less litigation $ 534,353   $ (315,275 )          

Reconciliation of operating expenses to operating expenses less litigation and reorganization related costs

  Operating expenses $ 3,931,161 $ 42,845,472   Litigation reserve - (36,303,643 ) Intangible asset impairment - (1,310,598 )

Fees associated with litigation and reorganization

  (382,887 )   (790,381 )  

Operating expenses less litigation and reorganization related costs

$ 3,548,274   $ 4,440,850